Between 11th and 13th January 2019, the CADF organised its certification seminar for Doping Control Officers (DCOs) at the Centre of Research & Expertise in Anti-Doping Sciences (REDs) in the University of Lausanne. 54 DCOs, including 5 new members, coming from 27 different countries attended this very important seminar that takes place every 2 years.
CADF collaborates with the UCI in the framework of the implementation of the tramadol ban Links to UCI Press Release
To Riders and Support Personnel The 2019 Prohibited List comes into effect on 1 January 2019. It is highly recommended that all Riders and Support Staff take the time to familiarize themselves with this important information. (Several languages below)
The Cycling Anti-Doping Foundation (CADF), the independent body mandated by the Union Cycliste Internationale (UCI) to define and carry out the fight against doping in cycling, has today signed a landmark agreement with Sportradar Integrity Services, the world’s leading provider of monitoring solutions that support the fight against betting-related match-fixing and corruption.
An out-of-competition doping control that was planned and carried out by the CADF on 31 July 2018 on the Belarusian rider Kanstantsin Siutsou returned an Adverse Analytical Finding (AAF) for Erythropoietin*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.org/inside-uci/press-releases/uci-statement-on-kanstantsin-siutsou). * Erythropoietin is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics (S2)” as per the World Anti-Doping Prohibited List
To find more about the CADF activities in 2017, please read
Aigle, Switzerland, July 4th, 2018 – Today, the Cycling Anti-Doping Foundation (CADF), the independent organisation mandated by the Union Cycliste Internationale (UCI) to define and manage the fight against doping in cycling, announced its strategy for the 2018 Tour de France starting on Saturday 7th July, which will be implemented in close cooperation with the Agence Française de Lutte contre le Dopage (AFLD), the National Anti-Doping Organisation of France.
On 14 June 2018, the CADF Funding Committee met in Geneva and welcomed two new members : Amina Lanaya, Director General of the Union Cycliste Internationale (UCI) and Luc Gheysens, representing the race organisers’ association (AIOCC).
The CADF is delighted to communicate the appointment of Mr. Andy Parkinson as new member of the CADF Foundation Board. Mr. Andy Parkinson is the Chief Executive Officer of British Rowing, having joined the organisation in this role in January 2015.
An intelligence-led doping test was carried out by the CADF in collaboration with the AFLD (Agence Française de Lutte contre le Dopage) and the OCLAEPS (Office Central de Lutte contre les Atteintes à l‘Environnement et la Santé Publique) on March the 8th 2018 on the French Rider Rémy Di Gregorio during the UCI WorldTour race Paris-Nice. The test returned an Adverse Analytical Finding (AAF) for Darbepoetin (dEPO)*. The rider was provisionally suspended by the UCI (Union Cycliste Internationale) and a press release was published on the UCI website (http://www.uci.ch/pressreleases/uci-statement-remy-gregorio/) * dEPO is classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List.”